Borneol increases blood–tumour barrier permeability by regulating the expression levels of tight junction-associated proteins

References

• Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. 2010. Structure and function of the blood–brain barrier. Neurobiol Dis. 37:13–25.
   PubMed Web of Science ®Google Scholar
• Bonetti A, Franceschi T, Apostoli P, Messori A, Sperotto L, Cetto GL, Molino A, Leone R. 1995. Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors. Ther Drug Monit. 17:25–32.
   PubMed Web of Science ®Google Scholar
• Chen YM, Wang NS. 2004. Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro blood–brain barrier model. Zhongguo Zhong Xi Yi Jie He Za Zhi. 24:632–634.
   PubMedGoogle Scholar
• Dasari S, Bernard Tchounwou P. 2014. Cisplatin in Cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 740:364–378.
   PubMed Web of Science ®Google Scholar
• Dong XZ, Tang XA, Gao QH, XU HB. 2002. Study on the auxo-action of Borneol assisting the penetration of DDB across BBB. Chinese Pharm J. 37:275–277.
   Google Scholar
• Ebrahimi Shahmabadi H, Movahedi F, Koohi Moftakhari Esfahani M, Alavi SE, Eslamifar A, Mohammadi Anaraki G, Akbarzadeh A. 2014. Efficacy of cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. Tumour Biol. 35:4799–4806.
   PubMed Web of Science ®Google Scholar
• Fischer S, Wobben M, Marti HH, Renz D, Schaper W. 2002. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 63:70–80.
   PubMed Web of Science ®Google Scholar
• Gage GJ, Kipke DR, Shain W. 2012. Whole animal perfusion fixation for rodents. J Vis Exp. 65:3564.
   PubMedGoogle Scholar
• Groothuis DR. 2000. The blood–brain and blood–tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncology. 2:45–59.
   PubMed Web of Science ®Google Scholar
• Harhaj NS, Antonetti DA. 2004. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol. 36:1206–1237.
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. 2004. Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 1027:48–58.
   PubMed Web of Science ®Google Scholar
• Heinke J, Juschkat M, Charlet A, Mnich L, Helbing T, Bode C, Patterson C, Moser M. 2013. Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation. J Cell Sci. 126:3082–3094.
   PubMed Web of Science ®Google Scholar
• Ishizaki T, Chiba H, Kojima T, Fujibe M, Soma T, Miyajima H, Nagasawa K, Wada I, Sawada N. 2003. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood–brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res. 290:275–288.
   PubMed Web of Science ®Google Scholar
• Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. 1999. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 147:1351–1363.
   PubMed Web of Science ®Google Scholar
• Jia ZY, Bai ZZ, Jiang LG, Zhang SJ, Duo K, Cui H, Yu YB, Liu P. 2010. Ocular pharmacokinetic study on baicalin in lens of rabbits following intragastric administration. Graefes Arch Clin Exp Ophthalmol. 248:59–63.
   PubMed Web of Science ®Google Scholar
• Jin D, Wang F, Qu LJ, Li ZT, Jin LH, Liu P, Xu XL, Cui H. 2011. The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment. Mol Biol Rep. 38:913–920.
   PubMed Web of Science ®Google Scholar
• Keiner D, Heimann A, Kronfeld A, Sommer C, Mueller-Forell W, Kempski O, Oertel J. 2014. Towards a glioma model for surgical technique evaluation in the rat. Br J Neurosurg. 28:86–92.
   PubMed Web of Science ®Google Scholar
• Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. 2009. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv. 6:1017–1032.
   PubMed Web of Science ®Google Scholar
• Lehman M, Thomas G. 2001. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer. 11:87–99.
   PubMed Web of Science ®Google Scholar
• Li WR, Yao LM, Mi SQ, Wang NS. 2004. The effect of borneol on level of HA and 5-HT in rat’s hypothalamus. Zhong Yao Cai. 27:937–939.
   PubMedGoogle Scholar
• Liang MR, Liu QD, Huang TL, Zhang YQ, Ou WP. 1993. The pharmacokinetic characteristics of borneol in serum and brain tissue of rats. Chin J New Drugs Clin Pharmacol. 4:38–40.
   Google Scholar
• Liebner S, Kniesel U, Kalbacher H, Wolburg H. 2000. Correlation of tight junction morphology with the expression of tight junction proteins in blood–brain barrier endothelial cells. Eur J Cell Biol. 79:707–717.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) Method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Madara JL. 1987. Intestinal absorptive cell tight junctions are linked tocytoskeleton. Am J Physiol. 253:171–175.
   PubMed Web of Science ®Google Scholar
• Mark KS, Davis TP. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 282:H1485–H1494.
   PubMedGoogle Scholar
• Park JM, Josan S, Jang TC, Merchant M, Yen YF, Hurd RE, Recht L, Spielman DM, Mayer D. 2012. Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-(13) C] pyruvate. Magn Reson Med. 68:1886–1893.
   PubMed Web of Science ®Google Scholar
• Paul CA, Beltz B, Berger-Sweeney J. 2008. Perfusion of brain tissues with fixative. CSH Protoc. 2008:pdb.prot4802. doi: 10.1101/pdb.prot4802.
   Google Scholar
• Salama NN, Eddington ND, Fasano A. 2006. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev. 58:15–28.
   PubMed Web of Science ®Google Scholar
• Samoto K, Perng GC, Ehtesham M, Liu Y, Wechsler SL, Nesburn AB, Black KL, Yu JS. 2001. A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation. Cancer Gene Ther. 8:269–277.
   PubMed Web of Science ®Google Scholar
• Soma T, Chiba H, Kato-Mori Y, Wada T, Yamashita T, Kojima T, Sawada N. 2004. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res. 300:202–212.
   PubMed Web of Science ®Google Scholar
• Song WG, Wang YF, Wang RL, Qu YE, Zhang Z, Li GZ, Xiao Y, Fang F, Chen H. 2013. Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pac J Cancer Prev. 14:923–927.
   PubMedGoogle Scholar
• Wang YY, Liu SC, Yang Z, Zhang T. 2011. Impaired hippocampal synaptic plasticity in C6 glioma-bearing rats. J Neurooncol. 103:469–477.
   PubMed Web of Science ®Google Scholar
• Wolburg H, Lippoldt T. 2002. Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul Pharmacol. 38:323–337.
   PubMed Web of Science ®Google Scholar
• Wu SR, Cheng G, He YX, Hao XH, Wang L, Sun J. 2004. Studies on the effects of borneol on the distribution of rifampicin in mice. Chin Pharm J. 39:288–291.
   Google Scholar
• Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. 1994. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54:4564–4568.
   PubMed Web of Science ®Google Scholar